Literature DB >> 12394323

Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study.

Christopher J Fox1, Digby J Cullen, Matthew W Knuiman, G Neil Cumpston, Mark L Divitini, Enrico Rossi, Peter A Gochee, Lawrie W Powell, John K Olynyk.   

Abstract

BACKGROUND: Increased iron stores and haemochromatosis gene mutations may be risk factors for coronary heart disease. The aims of this study were to determine in a stable community population whether increased iron stores or haemochromatosis gene mutations were risk factors for coronary heart disease.
DESIGN: Cross-sectional and prospective cohort studies.
METHODS: We evaluated 1185 men and 1141 women aged 20-79 years of predominantly Anglo-Celtic descent from the 1994-95 assessment of the Busselton population in Western Australia. Subjects underwent haemochromatosis genotyping, serum iron studies, clinical, biochemical and ECG evaluation for coronary heart disease and associated risk factors. Hospital admissions or death from cardiovascular disease were determined by linkage with the Western Australian morbidity and mortality database. The study design was cross-sectional for the 1994-95 cohort comparing coronary heart disease cases with unaffected subjects and unaffected subjects were followed prospectively until December 1998.
RESULTS: Cross-sectional and prospective cohort analyses demonstrated that elevated serum iron parameters or possession of either the C282Y or H63D mutations in the gene were not predictive of increased risk for coronary heart disease in men or women.
CONCLUSIONS: Increased iron stores or haemochromatosis gene mutations are not significant risk factors for coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394323     DOI: 10.1177/174182670200900510

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  4 in total

1.  Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies.

Authors:  Jacob Hunnicutt; Ka He; Pengcheng Xun
Journal:  J Nutr       Date:  2014-01-08       Impact factor: 4.798

2.  HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  James S Pankow; Eric Boerwinkle; Paul C Adams; Eliseo Guallar; Catherine Leiendecker-Foster; Jason Rogowski; John H Eckfeldt
Journal:  Transl Res       Date:  2008-06-13       Impact factor: 7.012

3.  Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.

Authors:  Núria Aranda; Fernando E Viteri; Carme Montserrat; Victoria Arija
Journal:  Ann Hematol       Date:  2010-01-28       Impact factor: 3.673

4.  A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study.

Authors:  Niwansa Adris; Anita Chai Geik Chua; Matthew William Knuiman; Mark Laurence Divitini; Debbie Trinder; John Kevin Olynyk
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.